Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)

PHASE4CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

May 10, 2021

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Epilepsies, Partial
Interventions
DRUG

Low dose carbamazepine

Carbamazepine, 300 mg/die

DRUG

Standard dose carbamazepine

Carbamazepine 600 mg/die

DRUG

Low dose levetiracetam

Levetiracetam 500 mg/die

DRUG

Standard dose levetiracetam

Levetiracetam 1000 mg/die

DRUG

Low dose valproate

Valproate 300 mg/die

DRUG

Standard dose valproate

Valproate 600 mg/die

DRUG

Low dose zonisamide

Zonisamide 150 mg/die

DRUG

Standard dose zonisamide

Zonisamide 300 mg/die

DRUG

Low dose oxcarbazepine

Oxcarbazepine 600 mg/die

DRUG

Standard dose oxcarbazepine

Oxcarbazepine 1200 mg/die

DRUG

Low dose topiramate

Topiramate 100 mg/die

DRUG

Standard dose topiramate

Topiramate 200 mg/die

DRUG

Low dose lamotrigine

Lamotrigine 100 mg/die

DRUG

Standard dose lamotrigine

Lamotrigine 200 mg/die

DRUG

Low dose gabapentin

Gabapentin 450 mg/die

DRUG

Standard dose gabapentin

Gabapentin 900 mg/die

Trial Locations (1)

20900

ASST Monza Ospedale San Gerardo, Monza

All Listed Sponsors
collaborator

Azienda Ospedaliera San Gerardo di Monza

OTHER

collaborator

Ministry of Health, Italy

OTHER_GOV

lead

Mario Negri Institute for Pharmacological Research

OTHER